|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2850103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13790269.8 |
| Date of filing the European patent application | 2013-05-17 | |
| (97) | Date of publication of the European application | 2015-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation | 2020-12-10 |
| (86) | Number | PCT/US2013/041656 |
| Date | 2013-05-17 |
| (87) | Number | WO 2013/173761 |
| Date | 2013-11-21 |
| (30) | Number | Date | Country code |
| 201261649147 P | 2012-05-18 | US | |
| 201361792619 P | 2013-03-15 | US |
| (72) |
SMITH, Dirk E., US
FOLTZ, Ian, CA
KING, Chadwick T., CA
LIM, Ai Ching, US
CLARK, Rutilio, US
COMEAU, Michael R., US
KETCHEM, Randal R., US
SHI, Donghui, US
MIN, Xiaoshan, US
WANG, Zhulun, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | ST2 antigeną surišantys baltymai |
| ST2 ANTIGEN BINDING PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 13 | 289.00 EUR |
| 2026-05-17 |